Clinical Trials in Italy / NCT03371121
Recruiting Not applicable

Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC

NCT03371121 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2016-04-26
Last updated
2017-12-13

Condition(s) studied

Talar Osteochondral Defect of AnklePainArthroscopy

Investigational drug(s) / intervention(s)

AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)

AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis): to fill arthroscopically osteochondral talar lesion

Study summary

Aim of the study is to evaluate clinical and radiographic outcomes in patients undergone all-arthroscopic autologous matrix induced chondrogenesis for symptomatic osteochondral talar lesions

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age over 18 years * males and females * patients underwent arthroscopic cartilage reconstruction surgery with AMIC technique for osteochondral lesions of the talus Exclusion Criteria: * age \<18 years at the time of surgery * patients with previous surgery on the affected ankle

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Federico Usuelli Milan Italy Recruiting

More I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03371121 on ClinicalTrials.gov ↗ ← All trials in Italy